{
  "Johnson & Johnson": {
    "2025": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 8 - Other Events": {
          "ITEMS": {
            "Item 8.01 - Other Events": {
              "content": "On February 26, 2025, Johnson & Johnson (the “Company”) completed the previously announced public offerings of the Notes under the Company’s Registration Statement on Form S-3, Reg. No. 333-269836. In connection with the offering of the Notes, the Company entered into an underwriting agreement on February 19, 2025, which is filed as Exhibit 1.1 hereto (the “Underwriting Agreement”), with Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, Goldman Sachs & Co. LLC and the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell the Notes to the Underwriters. The Underwriting Agreement incorporates the Underwriting Agreement Standard Provisions (Debt), dated February 18. 2025, which is filed as Exhibit 1.2 hereto.",
              "subsections": {
                "2029 Notes": "€600,000,000 aggregate principal amount of 2.700% Notes due 2029",
                "2033 Notes": "€700,000,000 aggregate principal amount of 3.050% Notes due 2033",
                "2037 Notes": "€1,000,000,000 aggregate principal amount of 3.350% Notes due 2037",
                "2045 Notes": "€700,000,000 aggregate principal amount of 3.600% Notes due 2045",
                "2055 Notes": "€1,000,000,000 aggregate principal amount of 3.700% Notes due 2055"
              }
            }
          }
        },
        "Section 9 - Financial Statements and Exhibits": {
          "ITEMS": {
            "Item 9.01 - Financial Statements and Exhibits": {
              "content": "(d) Exhibits.",
              "subsections": {
                "Exhibit 1.1": "Underwriting Agreement, dated February 19, 2025, among Johnson & Johnson and Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, Goldman Sachs & Co. LLC and the several Underwriters named therein.",
                "Exhibit 1.2": "Underwriting Agreement Standard Provisions (Debt) dated February 18, 2025 (Incorporated by reference to Exhibit 1.2 to the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on February 20, 2025).",
                "Exhibit 4.1": "Company Order establishing the terms of the Notes.",
                "Exhibit 4.2": "Form of 2.700% Notes due 2029.",
                "Exhibit 4.3": "Form of 3.050% Notes due 2033.",
                "Exhibit 4.4": "Form of 3.350% Notes due 2037.",
                "Exhibit 4.5": "Form of 3.600% Notes due 2045.",
                "Exhibit 4.6": "Form of 3.700% Notes due 2055.",
                "Exhibit 5.1": "Opinion of Weil, Gotshal & Manges LLP.",
                "Exhibit 5.2": "Opinion of Troutman Pepper Locke LLP.",
                "Exhibit 23.1": "Consent of Weil, Gotshal & Manges LLP (included in Exhibit 5.1 of this Current Report on Form 8-K).",
                "Exhibit 23.2": "Consent of Troutman Pepper Locke LLP (included in Exhibit 5.2 of this Current Report on Form 8-K).",
                "Exhibit 104": "The cover page of this Current Report on Form 8-K, formatted in Inline XBRL."
              }
            }
          }
        }
      }
    }
  }
}